AptarGroup, Inc.

ATR • Medical - Instruments & Supplies

$127.41

▼ -0.90 (-0.70%)

Precio actual

ResultadosÚltimo reporte: 30 jun 2026

PERFIL FAVORABLEAtractivaConfianza: 70%

Perfil cuantitativo — no constituye una recomendación de inversión.

Perfil cuantitativo — no constituye una recomendación de inversión.Metodología

Tesis del análisis: Alta calidad del negocio, con crecimiento y flujo de caja que respaldan el caso. La valoración todavía importa, pero el historial de ratios es favorable.

Capitalización

$8.22B

Crecimiento

7.3%

Flujo de caja

5/5

Tendencia

Stable

Evidencia

Márgenes estables o en mejora · 10.4%Flujo de caja libre positivo · 4.56Flujo de caja libre consistente · 5/5Múltiplo de ganancias razonable · 20.41Nivel de deuda manejable · 0.57

Datos financieros hasta: 30 jun 2026, 12:00 a.m. UTCÚltima actualización de earnings: 30 jun 2026, 12:00 a.m. UTCÚltima actualización del perfil: 5 ago 2026, 2:27 p.m. UTC

Resumen de la compañía

Valoración, calidad, fortaleza financiera, momentum y datos de analistas.

Price$127.41

Change-0.70%

Shares Out64.50M

Market Cap$8.22B

Enterprise Value$9.14B

52W Range103.23 - 158.12

Beta0.39

P/E22.67

P/S2.09

P/B296.46

P/FCF25.33

EV/Sales2.32

Price$127.41

Change-0.70%

Shares Out64.50M

Market Cap$8.22B

Enterprise Value$9.14B

52W Range103.23 - 158.12

Beta0.39

P/E22.67

P/S2.09

P/B296.46

P/FCF25.33

EV/Sales2.32

EV/EBITDA12.51

EV/FCF28.17

Earnings Yield4.41%

FCF Yield3.95%

Dividend Yield1.11%

Gross Margin29.58%

Oper. Margin13.56%

Profit Margin10.40%

Debt/Eq0.57

Current Ratio1.62

Quick Ratio1.16

Revenue 5Y7.31%

FCF 5Y11.89%

Target$160.00

Target Upside25.58%

Target Median$160.00

Target Range160.00 - 160.00

Volume492.22K

Avg Volume512.29K

EPS Surprise0.04

ADN de inversión

Qué tan fuerte luce esta compañía para inversionistas de largo plazo

de 100

Calidad del negocio

Márgenes, ventaja competitiva, retornos

71/100

Fortaleza financiera

Deuda, caja, estabilidad

82/100

Potencial de crecimiento

Ingresos y expansión

77/100

Atractivo del precio

Barata o cara hoy

73/100

Por qué este puntaje▼

Márgenes estables o en mejora · 10.4%Flujo de caja libre positivo · 4.56Flujo de caja libre consistente · 5/5Múltiplo de ganancias razonable · 20.41Nivel de deuda manejable · 0.57Liquidez saludable · 1.62

Analyst view

Analyst sentiment and price target

ATR

Analyst sentiment

Based on 18 analyst votes · 2026-09-05

64/100

Neutral

Bullish

Hold

Bearish

Precio objetivo

2026-07-31

Bajo

$156.00

Promedio

$158.00

Mediana

$158.00

Alto

$160.00

Resumen de la compañía

IPO: 4/23/1993

Industria: Medical - Instruments & Supplies

P/B i: 296.46

Deuda / Patrimonio i: 0.57

Margen operativo: 13.56%

Margen neto: 10.40%

ROE i: -

ROIC: -

Salud financiera

Puntaje16 / 20

Deuda / Patrimonio: 0.57

Ratio corriente: 1.62

Ratio rápido: 1.16

Estado: Strong

Transacciones internas

Actividad reciente de ejecutivos e insiders

Trerotola Matthew L.

Transacción: 07/16/2026

COMPRA

Cambio

+151

Precio

Not reported

Presentación

07/17/2026

Tipo

COMPRA

Xing Julie

Transacción: 07/16/2026

COMPRA

Cambio

+151

Precio

Not reported

Presentación

07/17/2026

Tipo

COMPRA

Glickman Sarah JS

Transacción: 07/16/2026

COMPRA

Cambio

+151

Precio

Not reported

Presentación

07/17/2026

Tipo

COMPRA

Insider	Tipo	Cambio	Precio	Transacción	Presentación
Trerotola Matthew L.	COMPRA	+151	Not reported	07/16/2026	07/17/2026
Xing Julie	COMPRA	+151	Not reported	07/16/2026	07/17/2026
Glickman Sarah JS	COMPRA	+151	Not reported	07/16/2026	07/17/2026
Owens B Craig	COMPRA	+151	Not reported	07/16/2026	07/17/2026
Wunderlich Ralf K.	COMPRA	+151	Not reported	07/16/2026	07/17/2026
Matthews Candace S.	COMPRA	+226	Not reported	07/16/2026	07/17/2026
Marey-Semper Isabel	COMPRA	+151	Not reported	07/16/2026	07/17/2026
Kampouri Monnas Giovanna	COMPRA	+151	Not reported	07/16/2026	07/17/2026
FOTIADES GEORGE L	COMPRA	+151	Not reported	07/16/2026	07/17/2026
Gandhi Aditya	COMPRA	+2,664	Not reported	06/15/2026	06/16/2026
Prieur Marc	VENTA	-447	$116.08	06/09/2026	06/10/2026
Gandhi Aditya	OTRO	0	Not reported	06/08/2026	06/08/2026
Vinczeller Shiela	VENTA	-213	$114.53	06/04/2026	06/05/2026
Gong Xiangwei	VENTA	-4,200	$116.13	05/26/2026	05/27/2026
Tlili Hedi	VENTA	-688	$116.50	05/21/2026	05/21/2026
Hudson Irene Elizabeth	VENTA	-842	$111.38	05/07/2026	05/08/2026
Hudson Irene Elizabeth	VENTA	-842	$123.45	05/07/2026	05/08/2026
Matthews Candace S.	COMPRA	+1,552	Not reported	05/06/2026	05/07/2026
Xing Julie	COMPRA	+1,326	Not reported	05/06/2026	05/07/2026
Wunderlich Ralf K.	COMPRA	+1,326	Not reported	05/06/2026	05/07/2026

Sobre la compañía

AptarGroup, Inc.

AptarGroup, Inc. specializes in developing and manufacturing solutions for dispensing, sealing, and advanced material science, catering to a broad spectrum of industries such as beauty, personal care, home care, and the pharmaceutical sector (including prescription drugs, consumer health care, and injectables), alongside the food and beverage markets. Its operations are structured into three key segments: Pharma, Beauty + Home, and Food + Beverage. The Pharma division offers critical components for the pharmaceutical industry, including pumps for nasal allergy remedies, metered dose inhaler valves vital for managing respiratory conditions like asthma and chronic obstructive pulmonary disease (COPD), elastomeric primary packaging for injectables, and sophisticated active material science innovations. The Beauty + Home segment primarily supplies the personal care and home care sectors with essential products such as pumps, various closures, aerosol valves, accompanying accessories, and sealing mechanisms. It also furnishes the beauty market with pumps and decorative elements. For the food and beverage industries, its Food + Beverage segment delivers a variety of dispensing and non-dispensing closures, specialized elastomeric flow control components, spray pumps, and aerosol valves. AptarGroup markets its offerings globally, utilizing its internal sales team, complemented by independent representatives and distributors across Asia, Europe, Latin America, and North America. The company is engaged in a strategic partnership with PureCycle Technologies LLC to pioneer the integration of ultra-pure recycled polypropylene into advanced dispensing applications. Additionally, it collaborates with Sonmol on the development of a digital platform providing therapies and services, with a particular focus on respiratory and other health conditions. Established in 1992, AptarGroup, Inc. maintains its corporate headquarters in Crystal Lake, Illinois.

Fuente - Link

Competidores

AVTR GMED GRFS HALO HSIC MASI MOH RGEN STVN TFX

Tamaño = capitalización · color = línea del gráfico

Rendimiento de peers · 1A

Top performers + empresa seleccionada

Ultimas Noticias

CytoSorbents Announces New Real-World Data Demonstrating Significant Reduction in Severe Bleeding Using CytoSorb in CABG Patients on Ticagrelor and Updates Recent DrugSorb-ATR FDA Pre-Submission Meetings

Patient-level matched analysis of real-world data demonstrated a significant 37% relative reduction in severe bleeding Significant reductions in 24-hour chest tube drainage and red blood cell transfusions were also seen, with no serious device-related adverse events reported Findings reinforce results from the STAR-T trial and are expected to form a core component of additional real-world evidence planned for a new U.S. FDA De Novo submission for DrugSorb-ATR® Recent FDA Pre-Submission meetings provided constructive feedback on potential U.S. regulatory pathways for DrugSorb-ATR for separate applications for ticagrelor and direct oral anticoagulant removal in urgent cardiac surgery PRINCETON, N.J., Sept. 2, 2026 /PRNewswire/ -- CytoSorbents Corporation (NASDAQ: CTSO), a leader in the treatment of life-threatening conditions in the intensive care unit and cardiac surgery using blood purification, today announced an independent new patient-level matched analysis of real-world data demonstrating that intraoperative use of CytoSorb was associated with a significant reduction in severe perioperative bleeding among patients undergoing urgent coronary artery bypass grafting (CABG) surgery on the blood thinner, ticagrelor (Brilinta®/Brilique®, AstraZeneca).

PRNewsWire

Callan Family Office LLC Makes New Investment in AptarGroup, Inc. $ATR

Callan Family Office LLC acquired a new stake in AptarGroup, Inc. (NYSE: ATR) during the quarter, according to the company in its most recent 13F filing with the Securities and Exchange Commission. The institutional investor acquired 9,429 shares of the industrial products company's stock, valued at approximately $1,181,000. A number of other

Defense World

Deutsche Bank AG Invests $14.90 Million in AptarGroup, Inc. $ATR

Deutsche Bank AG bought a new stake in AptarGroup, Inc. (NYSE: ATR) in the second quarter, according to the company in its most recent filing with the Securities and Exchange Commission. The firm bought 119,035 shares of the industrial products company's stock, valued at approximately $14,903,000. Deutsche Bank AG owned approximately 0.19% of

Defense World

Aurora Investment Counsel Acquires New Stake in AptarGroup, Inc. $ATR

Aurora Investment Counsel acquired a new stake in shares of AptarGroup, Inc. (NYSE: ATR) in the second quarter, according to the company in its most recent filing with the Securities and Exchange Commission (SEC). The fund acquired 11,785 shares of the industrial products company's stock, valued at approximately $1,475,000. Other hedge funds have

Defense World

Dividend Champion, Contender, And Challenger Highlights: Week August 16

A weekly summary of dividend activity for Dividend Champions, Contenders, and Challengers. Companies which changed their dividends. Companies with upcoming ex-dividend dates.

Seeking Alpha

Sorpresas de ganancias

Período	Estimado	Real	Sorpresa
2026-04-30	1.15	1.19	0.04
2026-02-05	1.24	1.25	0.01
2025-10-30	1.57	1.62	0.05
2025-07-31	1.58	1.66	0.08
2025-05-01	1.16	1.2	0.04
2025-02-06	1.28	1.52	0.24
2024-10-24	1.42	1.49	0.07
2024-07-25	1.36	1.37	0.01
2024-04-25	1.15	1.26	0.11
2024-02-08	1.12	1.21	0.09
2023-10-25	1.27	1.39	0.12
2023-07-27	1.14	1.23	0.09